Bharat Parenterals Limited (BOM:541096)
India · Delayed Price · Currency is INR 1,026.30
-14.60 (-1.40%)
At close: Feb 12, 2026
Bharat Parenterals Market Cap
Bharat Parenterals has a market cap or net worth of 7.2 billion as of February 13, 2026. Its market cap has decreased by -13.81% in one year.
Market Cap
7.20B
Enterprise Value
8.28B
Revenue
3.50B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,026.30
Market Cap Chart
Since March 21, 2018, Bharat Parenterals's market cap has increased from 914.45M to 7.20B, an increase of 687.13%. That is a compound annual growth rate of 29.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 7.20B | -13.65% |
| Dec 31, 2025 | 8.34B | -12.96% |
| Dec 31, 2024 | 9.58B | 103.12% |
| Dec 29, 2023 | 4.71B | 148.91% |
| Dec 30, 2022 | 1.89B | -13.76% |
| Dec 31, 2021 | 2.20B | 8.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 9.96B |
| Wanbury | 9.32B |
| Fermenta Biotech | 9.21B |
| Fredun Pharmaceuticals | 8.62B |
| Anuh Pharma | 8.23B |
| Accent Microcell | 6.88B |
| Kopran | 6.58B |
| Sudarshan Pharma Industries | 6.18B |